Daily Target 2X Long MRNA ETF
ETFYour view on MRNX
Daily Target 2X Long MRNA ETF
ETFDefianceSentiment
AUM (USD)
$3.05M
Expense Ratio
1.31%
Holdings
9
Sentiment
Overview for Daily Target 2X Long MRNA ETF
- Fund Type
- ETF
- Fund Issuer
- Defiance
- Asset Class
- N/A
- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Inception Date
- February 3, 2026
- Domicile
- US
- Website
- defianceetfs.com/mrnx
- Fund Type
- ETF
- Fund Issuer
- Defiance
- Asset Class
- N/A
- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Inception Date
- February 3, 2026
- Domicile
- US
- Website
- defianceetfs.com/mrnx
- Fund Type
- ETF
- Fund Issuer
- Defiance
- Asset Class
- N/A
- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Inception Date
- February 3, 2026
- Domicile
- US
- Website
- defianceetfs.com/mrnx
About this fund
The MRNX fund is designed to generate returns by taking a leveraged, bullish stance on the daily share price movements of Moderna, Inc. (MRNA). It achieves this primarily through the use of swap agreements and short-term listed call options. Its objective is to deliver a daily re…
MRNX Stock Price
Key Facts
Expense Ratio
1.31%
AUM
$3.05M
Fund Details
Expense Ratio
1.31%
Assets Under Management
$3.05M
NAV
$25.45 USD
Holdings
9
Average Volume
34.8K
Inception Date
February 3, 2026
Fund Issuer
Defiance
Domicile
US
ISIN
US88636X8157
CUSIP
88636X815
NAV Currency
USD
Expense Ratio
1.31%
Assets Under Management
$3.05M
NAV
$25.45 USD
Holdings
9
Average Volume
34.8K
Inception Date
February 3, 2026
Fund Issuer
Defiance
Domicile
US
ISIN
US88636X8157
CUSIP
88636X815
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.